Attend the FierceBiotech 3rd Drug Development Forum!
The leading executive-level forum for biotech strategy & networking | Oct 1-3 | Boston
AOBiome is running an iPhone-enabled Phase IIb trial of its bacterial treatment for acne with Novartis ($NVS)-backed virtual trial CRO Science 37.
Tute Genomics is crowdfunding a DNA sequencing scheme. The campaign is aiming to raise $100,000 by offering whole genome sequencing for between $999 and $1,499.
Medidata has signed up to provide its cloud platform and mobile health capabilities to Techfields Pharma.
Trialbee has added ex-Lundbeck CEO Ulf Wiinberg and former Bristol-Myers Squibb SVP Lars Birgerson to its board of directors.
Apple has bought three-year-old startup Gliimpse to build out its health data capabilities.
The team that founded Firecrest Clinical and led it to a takeout by CRO Icon has raised $6 million for its next startup, teckro.
TrialReach has named former Google Ventures Europe partner Eze Vidra as its chief innovation officer.
Medisafe has started pitching an app and services to increase medication adherence and facilitate patient recruitment to biopharma companies.
Bioz has exited stealth with funding from 5AM Ventures and a platform it sees as taking some of the drudgery and guesswork out of sourcing research products.
PatientsLikeMe has lured Marni Hall away from the FDA. Hall will now work to turn patient-reported data into tools that improve research and health outcomes.